Gyre Therapeutics, Inc. (GYRE) Operating margin 2017–2025
Gyre Therapeutics, Inc. (GYRE) operating margin by fiscal year — reported operating income divided by reported revenue.
9.9%FY2025 · since FY2017: -2143.6% → 9.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.9% | -5.4 pp |
| FY2024 | 15.3% | +74.5 pp |
| FY2023 | -59.3% | -68.3 pp |
| FY2022 | 9.0% | +1206.8 pp |
| FY2021 | -1197.8% | -923.9 pp |
| FY2020 | -273.9% | — |
| FY2018 | -563700.0% | -561556.4 pp |
| FY2017 | -2143.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice